[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Lacidipine Market Growth 2022-2028

October 2022 | 108 pages | ID: GB7E28938C66EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global market for Lacidipine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Lacidipine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Lacidipine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Lacidipine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Lacidipine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Lacidipine players cover Dr. Reddy's Laboratories (UK), Rivopharm, Pliva, West Coast and GSK, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Lacidipine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Lacidipine market, with both quantitative and qualitative data, to help readers understand how the Lacidipine market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:

The study segments the Lacidipine market and forecasts the market size by Type (2 mg, 4 mg and 6 mg), by Application (Online Pharmacy and Offline Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
  • 2 mg
  • 4 mg
  • 6 mg
Segmentation by application
  • Online Pharmacy
  • Offline Pharmacy
Segmentation by region
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Major companies covered
  • Dr. Reddy's Laboratories (UK)
  • Rivopharm
  • Pliva
  • West Coast
  • GSK
  • Creo Pharma
  • NIKSAN HEALTHCARE
  • Dideu Group
  • Incepta Pharmaceuticals
  • Synmosa Biopharma
  • Square Pharmaceuticals
  • Harbin Pharmaceutical Group
  • Zhejiang Better Pharmaceuticals
Chapter Introduction

Chapter 1: Scope of Lacidipine, Research Methodology, etc.

Chapter 2: Executive Summary, global Lacidipine market size (sales and revenue) and CAGR, Lacidipine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Lacidipine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Lacidipine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Lacidipine market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including Dr. Reddy's Laboratories (UK), Rivopharm, Pliva, West Coast, GSK, Creo Pharma, NIKSAN HEALTHCARE, Dideu Group and Incepta Pharmaceuticals, etc.

Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lacidipine Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Lacidipine by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Lacidipine by Country/Region, 2017, 2022 & 2028
2.2 Lacidipine Segment by Type
  2.2.1 2 mg
  2.2.2 4 mg
  2.2.3 6 mg
2.3 Lacidipine Sales by Type
  2.3.1 Global Lacidipine Sales Market Share by Type (2017-2022)
  2.3.2 Global Lacidipine Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Lacidipine Sale Price by Type (2017-2022)
2.4 Lacidipine Segment by Application
  2.4.1 Online Pharmacy
  2.4.2 Offline Pharmacy
2.5 Lacidipine Sales by Application
  2.5.1 Global Lacidipine Sale Market Share by Application (2017-2022)
  2.5.2 Global Lacidipine Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Lacidipine Sale Price by Application (2017-2022)

3 GLOBAL LACIDIPINE BY COMPANY

3.1 Global Lacidipine Breakdown Data by Company
  3.1.1 Global Lacidipine Annual Sales by Company (2020-2022)
  3.1.2 Global Lacidipine Sales Market Share by Company (2020-2022)
3.2 Global Lacidipine Annual Revenue by Company (2020-2022)
  3.2.1 Global Lacidipine Revenue by Company (2020-2022)
  3.2.2 Global Lacidipine Revenue Market Share by Company (2020-2022)
3.3 Global Lacidipine Sale Price by Company
3.4 Key Manufacturers Lacidipine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lacidipine Product Location Distribution
  3.4.2 Players Lacidipine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR LACIDIPINE BY GEOGRAPHIC REGION

4.1 World Historic Lacidipine Market Size by Geographic Region (2017-2022)
  4.1.1 Global Lacidipine Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Lacidipine Annual Revenue by Geographic Region
4.2 World Historic Lacidipine Market Size by Country/Region (2017-2022)
  4.2.1 Global Lacidipine Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Lacidipine Annual Revenue by Country/Region
4.3 Americas Lacidipine Sales Growth
4.4 APAC Lacidipine Sales Growth
4.5 Europe Lacidipine Sales Growth
4.6 Middle East & Africa Lacidipine Sales Growth

5 AMERICAS

5.1 Americas Lacidipine Sales by Country
  5.1.1 Americas Lacidipine Sales by Country (2017-2022)
  5.1.2 Americas Lacidipine Revenue by Country (2017-2022)
5.2 Americas Lacidipine Sales by Type
5.3 Americas Lacidipine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lacidipine Sales by Region
  6.1.1 APAC Lacidipine Sales by Region (2017-2022)
  6.1.2 APAC Lacidipine Revenue by Region (2017-2022)
6.2 APAC Lacidipine Sales by Type
6.3 APAC Lacidipine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lacidipine by Country
  7.1.1 Europe Lacidipine Sales by Country (2017-2022)
  7.1.2 Europe Lacidipine Revenue by Country (2017-2022)
7.2 Europe Lacidipine Sales by Type
7.3 Europe Lacidipine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lacidipine by Country
  8.1.1 Middle East & Africa Lacidipine Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Lacidipine Revenue by Country (2017-2022)
8.2 Middle East & Africa Lacidipine Sales by Type
8.3 Middle East & Africa Lacidipine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lacidipine
10.3 Manufacturing Process Analysis of Lacidipine
10.4 Industry Chain Structure of Lacidipine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lacidipine Distributors
11.3 Lacidipine Customer

12 WORLD FORECAST REVIEW FOR LACIDIPINE BY GEOGRAPHIC REGION

12.1 Global Lacidipine Market Size Forecast by Region
  12.1.1 Global Lacidipine Forecast by Region (2023-2028)
  12.1.2 Global Lacidipine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lacidipine Forecast by Type
12.7 Global Lacidipine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Dr. Reddy's Laboratories (UK)
  13.1.1 Dr. Reddy's Laboratories (UK) Company Information
  13.1.2 Dr. Reddy's Laboratories (UK) Lacidipine Product Offered
  13.1.3 Dr. Reddy's Laboratories (UK) Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Dr. Reddy's Laboratories (UK) Main Business Overview
  13.1.5 Dr. Reddy's Laboratories (UK) Latest Developments
13.2 Rivopharm
  13.2.1 Rivopharm Company Information
  13.2.2 Rivopharm Lacidipine Product Offered
  13.2.3 Rivopharm Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Rivopharm Main Business Overview
  13.2.5 Rivopharm Latest Developments
13.3 Pliva
  13.3.1 Pliva Company Information
  13.3.2 Pliva Lacidipine Product Offered
  13.3.3 Pliva Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Pliva Main Business Overview
  13.3.5 Pliva Latest Developments
13.4 West Coast
  13.4.1 West Coast Company Information
  13.4.2 West Coast Lacidipine Product Offered
  13.4.3 West Coast Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 West Coast Main Business Overview
  13.4.5 West Coast Latest Developments
13.5 GSK
  13.5.1 GSK Company Information
  13.5.2 GSK Lacidipine Product Offered
  13.5.3 GSK Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 GSK Main Business Overview
  13.5.5 GSK Latest Developments
13.6 Creo Pharma
  13.6.1 Creo Pharma Company Information
  13.6.2 Creo Pharma Lacidipine Product Offered
  13.6.3 Creo Pharma Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Creo Pharma Main Business Overview
  13.6.5 Creo Pharma Latest Developments
13.7 NIKSAN HEALTHCARE
  13.7.1 NIKSAN HEALTHCARE Company Information
  13.7.2 NIKSAN HEALTHCARE Lacidipine Product Offered
  13.7.3 NIKSAN HEALTHCARE Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 NIKSAN HEALTHCARE Main Business Overview
  13.7.5 NIKSAN HEALTHCARE Latest Developments
13.8 Dideu Group
  13.8.1 Dideu Group Company Information
  13.8.2 Dideu Group Lacidipine Product Offered
  13.8.3 Dideu Group Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Dideu Group Main Business Overview
  13.8.5 Dideu Group Latest Developments
13.9 Incepta Pharmaceuticals
  13.9.1 Incepta Pharmaceuticals Company Information
  13.9.2 Incepta Pharmaceuticals Lacidipine Product Offered
  13.9.3 Incepta Pharmaceuticals Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Incepta Pharmaceuticals Main Business Overview
  13.9.5 Incepta Pharmaceuticals Latest Developments
13.10 Synmosa Biopharma
  13.10.1 Synmosa Biopharma Company Information
  13.10.2 Synmosa Biopharma Lacidipine Product Offered
  13.10.3 Synmosa Biopharma Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Synmosa Biopharma Main Business Overview
  13.10.5 Synmosa Biopharma Latest Developments
13.11 Square Pharmaceuticals
  13.11.1 Square Pharmaceuticals Company Information
  13.11.2 Square Pharmaceuticals Lacidipine Product Offered
  13.11.3 Square Pharmaceuticals Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Square Pharmaceuticals Main Business Overview
  13.11.5 Square Pharmaceuticals Latest Developments
13.12 Harbin Pharmaceutical Group
  13.12.1 Harbin Pharmaceutical Group Company Information
  13.12.2 Harbin Pharmaceutical Group Lacidipine Product Offered
  13.12.3 Harbin Pharmaceutical Group Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 Harbin Pharmaceutical Group Main Business Overview
  13.12.5 Harbin Pharmaceutical Group Latest Developments
13.13 Zhejiang Better Pharmaceuticals
  13.13.1 Zhejiang Better Pharmaceuticals Company Information
  13.13.2 Zhejiang Better Pharmaceuticals Lacidipine Product Offered
  13.13.3 Zhejiang Better Pharmaceuticals Lacidipine Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 Zhejiang Better Pharmaceuticals Main Business Overview
  13.13.5 Zhejiang Better Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Lacidipine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lacidipine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2 mg
Table 4. Major Players of 4 mg
Table 5. Major Players of 6 mg
Table 6. Global Lacidipine Sales by Type (2017-2022) & (K Units)
Table 7. Global Lacidipine Sales Market Share by Type (2017-2022)
Table 8. Global Lacidipine Revenue by Type (2017-2022) & ($ million)
Table 9. Global Lacidipine Revenue Market Share by Type (2017-2022)
Table 10. Global Lacidipine Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Lacidipine Sales by Application (2017-2022) & (K Units)
Table 12. Global Lacidipine Sales Market Share by Application (2017-2022)
Table 13. Global Lacidipine Revenue by Application (2017-2022)
Table 14. Global Lacidipine Revenue Market Share by Application (2017-2022)
Table 15. Global Lacidipine Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Lacidipine Sales by Company (2020-2022) & (K Units)
Table 17. Global Lacidipine Sales Market Share by Company (2020-2022)
Table 18. Global Lacidipine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Lacidipine Revenue Market Share by Company (2020-2022)
Table 20. Global Lacidipine Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Lacidipine Producing Area Distribution and Sales Area
Table 22. Players Lacidipine Products Offered
Table 23. Lacidipine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Lacidipine Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Lacidipine Sales Market Share Geographic Region (2017-2022)
Table 28. Global Lacidipine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Lacidipine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Lacidipine Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Lacidipine Sales Market Share by Country/Region (2017-2022)
Table 32. Global Lacidipine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Lacidipine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Lacidipine Sales by Country (2017-2022) & (K Units)
Table 35. Americas Lacidipine Sales Market Share by Country (2017-2022)
Table 36. Americas Lacidipine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Lacidipine Revenue Market Share by Country (2017-2022)
Table 38. Americas Lacidipine Sales by Type (2017-2022) & (K Units)
Table 39. Americas Lacidipine Sales Market Share by Type (2017-2022)
Table 40. Americas Lacidipine Sales by Application (2017-2022) & (K Units)
Table 41. Americas Lacidipine Sales Market Share by Application (2017-2022)
Table 42. APAC Lacidipine Sales by Region (2017-2022) & (K Units)
Table 43. APAC Lacidipine Sales Market Share by Region (2017-2022)
Table 44. APAC Lacidipine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Lacidipine Revenue Market Share by Region (2017-2022)
Table 46. APAC Lacidipine Sales by Type (2017-2022) & (K Units)
Table 47. APAC Lacidipine Sales Market Share by Type (2017-2022)
Table 48. APAC Lacidipine Sales by Application (2017-2022) & (K Units)
Table 49. APAC Lacidipine Sales Market Share by Application (2017-2022)
Table 50. Europe Lacidipine Sales by Country (2017-2022) & (K Units)
Table 51. Europe Lacidipine Sales Market Share by Country (2017-2022)
Table 52. Europe Lacidipine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Lacidipine Revenue Market Share by Country (2017-2022)
Table 54. Europe Lacidipine Sales by Type (2017-2022) & (K Units)
Table 55. Europe Lacidipine Sales Market Share by Type (2017-2022)
Table 56. Europe Lacidipine Sales by Application (2017-2022) & (K Units)
Table 57. Europe Lacidipine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Lacidipine Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Lacidipine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Lacidipine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Lacidipine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Lacidipine Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Lacidipine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Lacidipine Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Lacidipine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Lacidipine
Table 67. Key Market Challenges & Risks of Lacidipine
Table 68. Key Industry Trends of Lacidipine
Table 69. Lacidipine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Lacidipine Distributors List
Table 72. Lacidipine Customer List
Table 73. Global Lacidipine Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Lacidipine Sales Market Forecast by Region
Table 75. Global Lacidipine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Lacidipine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Lacidipine Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Lacidipine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Lacidipine Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Lacidipine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Lacidipine Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Lacidipine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Lacidipine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Lacidipine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Lacidipine Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Lacidipine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Lacidipine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Lacidipine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Lacidipine Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Lacidipine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Lacidipine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Lacidipine Revenue Market Share Forecast by Application (2023-2028)
Table 93. Dr. Reddy's Laboratories (UK) Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 94. Dr. Reddy's Laboratories (UK) Lacidipine Product Offered
Table 95. Dr. Reddy's Laboratories (UK) Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Dr. Reddy's Laboratories (UK) Main Business
Table 97. Dr. Reddy's Laboratories (UK) Latest Developments
Table 98. Rivopharm Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 99. Rivopharm Lacidipine Product Offered
Table 100. Rivopharm Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Rivopharm Main Business
Table 102. Rivopharm Latest Developments
Table 103. Pliva Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 104. Pliva Lacidipine Product Offered
Table 105. Pliva Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Pliva Main Business
Table 107. Pliva Latest Developments
Table 108. West Coast Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 109. West Coast Lacidipine Product Offered
Table 110. West Coast Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. West Coast Main Business
Table 112. West Coast Latest Developments
Table 113. GSK Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 114. GSK Lacidipine Product Offered
Table 115. GSK Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. GSK Main Business
Table 117. GSK Latest Developments
Table 118. Creo Pharma Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 119. Creo Pharma Lacidipine Product Offered
Table 120. Creo Pharma Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Creo Pharma Main Business
Table 122. Creo Pharma Latest Developments
Table 123. NIKSAN HEALTHCARE Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 124. NIKSAN HEALTHCARE Lacidipine Product Offered
Table 125. NIKSAN HEALTHCARE Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. NIKSAN HEALTHCARE Main Business
Table 127. NIKSAN HEALTHCARE Latest Developments
Table 128. Dideu Group Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 129. Dideu Group Lacidipine Product Offered
Table 130. Dideu Group Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Dideu Group Main Business
Table 132. Dideu Group Latest Developments
Table 133. Incepta Pharmaceuticals Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 134. Incepta Pharmaceuticals Lacidipine Product Offered
Table 135. Incepta Pharmaceuticals Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Incepta Pharmaceuticals Main Business
Table 137. Incepta Pharmaceuticals Latest Developments
Table 138. Synmosa Biopharma Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 139. Synmosa Biopharma Lacidipine Product Offered
Table 140. Synmosa Biopharma Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Synmosa Biopharma Main Business
Table 142. Synmosa Biopharma Latest Developments
Table 143. Square Pharmaceuticals Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 144. Square Pharmaceuticals Lacidipine Product Offered
Table 145. Square Pharmaceuticals Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Square Pharmaceuticals Main Business
Table 147. Square Pharmaceuticals Latest Developments
Table 148. Harbin Pharmaceutical Group Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 149. Harbin Pharmaceutical Group Lacidipine Product Offered
Table 150. Harbin Pharmaceutical Group Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Harbin Pharmaceutical Group Main Business
Table 152. Harbin Pharmaceutical Group Latest Developments
Table 153. Zhejiang Better Pharmaceuticals Basic Information, Lacidipine Manufacturing Base, Sales Area and Its Competitors
Table 154. Zhejiang Better Pharmaceuticals Lacidipine Product Offered
Table 155. Zhejiang Better Pharmaceuticals Lacidipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Zhejiang Better Pharmaceuticals Main Business
Table 157. Zhejiang Better Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Picture of Lacidipine
Figure 2. Lacidipine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lacidipine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Lacidipine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lacidipine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2 mg
Figure 10. Product Picture of 4 mg
Figure 11. Product Picture of 6 mg
Figure 12. Global Lacidipine Sales Market Share by Type in 2021
Figure 13. Global Lacidipine Revenue Market Share by Type (2017-2022)
Figure 14. Lacidipine Consumed in Online Pharmacy
Figure 15. Global Lacidipine Market: Online Pharmacy (2017-2022) & (K Units)
Figure 16. Lacidipine Consumed in Offline Pharmacy
Figure 17. Global Lacidipine Market: Offline Pharmacy (2017-2022) & (K Units)
Figure 18. Global Lacidipine Sales Market Share by Application (2017-2022)
Figure 19. Global Lacidipine Revenue Market Share by Application in 2021
Figure 20. Lacidipine Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Lacidipine Revenue Market Share by Company in 2021
Figure 22. Global Lacidipine Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Lacidipine Revenue Market Share by Geographic Region in 2021
Figure 24. Global Lacidipine Sales Market Share by Region (2017-2022)
Figure 25. Global Lacidipine Revenue Market Share by Country/Region in 2021
Figure 26. Americas Lacidipine Sales 2017-2022 (K Units)
Figure 27. Americas Lacidipine Revenue 2017-2022 ($ Millions)
Figure 28. APAC Lacidipine Sales 2017-2022 (K Units)
Figure 29. APAC Lacidipine Revenue 2017-2022 ($ Millions)
Figure 30. Europe Lacidipine Sales 2017-2022 (K Units)
Figure 31. Europe Lacidipine Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Lacidipine Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Lacidipine Revenue 2017-2022 ($ Millions)
Figure 34. Americas Lacidipine Sales Market Share by Country in 2021
Figure 35. Americas Lacidipine Revenue Market Share by Country in 2021
Figure 36. United States Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Lacidipine Sales Market Share by Region in 2021
Figure 41. APAC Lacidipine Revenue Market Share by Regions in 2021
Figure 42. China Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Lacidipine Sales Market Share by Country in 2021
Figure 49. Europe Lacidipine Revenue Market Share by Country in 2021
Figure 50. Germany Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Lacidipine Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Lacidipine Revenue Market Share by Country in 2021
Figure 57. Egypt Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Lacidipine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Lacidipine in 2021
Figure 63. Manufacturing Process Analysis of Lacidipine
Figure 64. Industry Chain Structure of Lacidipine
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles


More Publications